Based on histopathological criteria including the expression of estrogen receptor (ER), progesterone receptor (PR) and/or human epidermal growth factor receptor 2 (HER2), BC is classified into four major subtypes: Luminal A, Luminal B, HER2-positive, and basal-like3. Here, PGR is linked to breast cancer.